Found: 34
Select item for more details and to access through your institution.
Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION‐8 randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1520, doi. 10.1111/dom.13296
- By:
- Publication type:
- Article
Cover Image, Volume 20, Issue 6.
- Published in:
- 2018
- By:
- Publication type:
- Cover Art
Comment on: “Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post‐hoc analysis of the AWARD‐2, −4 and −5 trials”.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: <italic>Post‐hoc</italic> analysis of concomitant add‐on versus sequential add‐on to metformin and of triple versus dual therapy with metformin.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1542, doi. 10.1111/dom.13258
- By:
- Publication type:
- Article
Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1479, doi. 10.1111/dom.13257
- By:
- Publication type:
- Article
Residual confounding in the study by van Dalem et al.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
A 52‐week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add‐on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1535, doi. 10.1111/dom.13256
- By:
- Publication type:
- Article
Prolonged uninterrupted sitting elevates postprandial hyperglycaemia proportional to degree of insulin resistance.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1526, doi. 10.1111/dom.13254
- By:
- Publication type:
- Article
SGLT‐2 inhibitors and the risk of lower‐limb amputation: Is this a class effect?
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1531, doi. 10.1111/dom.13255
- By:
- Publication type:
- Article
Direct medical costs of diabetes mellitus in the year of mortality and year preceding the year of mortality.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1470, doi. 10.1111/dom.13253
- By:
- Publication type:
- Article
Long‐term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1453, doi. 10.1111/dom.13251
- By:
- Publication type:
- Article
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1369, doi. 10.1111/dom.13245
- By:
- Publication type:
- Article
<italic>HNF1A</italic> variant, energy‐reduced diets and insulin resistance improvement during weight loss: The POUNDS Lost trial and DIRECT.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1445, doi. 10.1111/dom.13250
- By:
- Publication type:
- Article
Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1337, doi. 10.1111/dom.13243
- By:
- Publication type:
- Article
Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow‐up: A subgroup analysis of high‐risk ACCORDION trial participants.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1499, doi. 10.1111/dom.13248
- By:
- Publication type:
- Article
Dulaglutide 1.5 mg as an add‐on option for patients uncontrolled on insulin: Subgroup analysis by age, duration of diabetes and baseline glycated haemoglobin concentration.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1461, doi. 10.1111/dom.13252
- By:
- Publication type:
- Article
Cardiovascular biomarkers in clinical studies of type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1350, doi. 10.1111/dom.13247
- By:
- Publication type:
- Article
Metformin does not affect postabsorptive hepatic free fatty acid uptake, oxidation or resecretion in humans: A 3‐month placebo‐controlled clinical trial in patients with type 2 diabetes and healthy controls.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1435, doi. 10.1111/dom.13244
- By:
- Publication type:
- Article
Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1427, doi. 10.1111/dom.13242
- By:
- Publication type:
- Article
Specific synbiotics in early life protect against diet‐induced obesity in adult mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1408, doi. 10.1111/dom.13240
- By:
- Publication type:
- Article
Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1419, doi. 10.1111/dom.13241
- By:
- Publication type:
- Article
Accuracy and precision of flash glucose monitoring sensors inserted into the abdomen and upper thigh compared with the upper arm.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1503, doi. 10.1111/dom.13239
- By:
- Publication type:
- Article
Perspectives on diabetes mortality as the result of residual confounding and reverse causality by common disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1342, doi. 10.1111/dom.13238
- By:
- Publication type:
- Article
Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A <italic>post‐hoc</italic> analysis of the AWARD‐2, ‐4 and ‐5 Trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1490, doi. 10.1111/dom.13237
- By:
- Publication type:
- Article
Two‐year trial of intermittent insulin therapy vs metformin for the preservation of β‐cell function after initial short‐term intensive insulin induction in early type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1399, doi. 10.1111/dom.13236
- By:
- Publication type:
- Article
Effect of proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies on new‐onset diabetes mellitus and glucose metabolism: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1391, doi. 10.1111/dom.13235
- By:
- Publication type:
- Article
Antibiotic exposure in early life and childhood overweight and obesity: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1508, doi. 10.1111/dom.13230
- By:
- Publication type:
- Article
Counterpoint to the hypothesis that SGLT2 inhibitors protect the heart by antagonizing leptin.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1367, doi. 10.1111/dom.13234
- By:
- Publication type:
- Article
Do sodium‐glucose co‐transporter‐2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1361, doi. 10.1111/dom.13229
- By:
- Publication type:
- Article
Morbid obesity and type 2 diabetes alter intestinal fatty acid uptake and blood flow.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1384, doi. 10.1111/dom.13228
- By:
- Publication type:
- Article
Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1377, doi. 10.1111/dom.13226
- By:
- Publication type:
- Article
Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION‐8 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1515, doi. 10.1111/dom.13206
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1333, doi. 10.1111/dom.13094
- Publication type:
- Article